Package Leaflet: Information for the User
Fampridine Sun 10 mg prolonged-release tablets EFG
fampridine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Fampridine Sun is a medicine used to improve walking in adults (18 years or older) with multiple sclerosis (MS) who have walking disability. In multiple sclerosis, inflammation damages the protective covering of the nerves, leading to muscle weakness, muscle stiffness, and difficulty walking.
Fampridine Sun contains the active substance fampridine, which belongs to a group of medicines called potassium channel blockers. They work by slowing down the release of potassium from damaged nerve cells in MS. It is thought that this medicine works by allowing signals to pass through the nerve in a more normal way, which helps you to walk better.
Do not take Fampridine Sun
Tell your doctor and do not take Fampridine Sun if any of these apply to you.
If you are not sure, consult your doctor before taking this medicine.
Warnings and precautions
Consult your doctor or pharmacist before starting Fampridine Sun:
Tell your doctor before taking Fampridine Sun if any of these apply to you.
Children and adolescents
Do not give Fampridine Sun to children or adolescents under 18 years.
Elderly
Before starting treatment and during treatment, your doctor may check that your kidneys are working properly.
Other medicines and Fampridine Sun
Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines.
Do not take Fampridine Sun if you are taking other medicines that contain fampridine.
Other medicines that affect the kidneys
Your doctor will be careful if you are given fampridine at the same time as another medicine that may affect how other medicines are removed from the body by the kidneys, such as carvedilol, propranolol, and metformin.
Taking Fampridine Sun with food and drinks
Fampridine Sun should be taken on an empty stomach, without food.
Pregnancy and breastfeeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Fampridine Sun is not recommended during pregnancy.
Your doctor will assess the benefits of treatment with this medicine for you against the risks for your baby.
Breast-feeding should be stopped during treatment with this medicine.
Driving and using machines
Fampridine can affect your ability to drive or use machines, it can cause dizziness. Make sure it does not affect you before you start driving or using machines.
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure. You can only get Fampridine Sun with a prescription and under the supervision of doctors with experience in MS.
Your doctor will initially prescribe treatment for 2 to 4 weeks. After this 2 to 4 week period, the treatment will be re-evaluated.
The recommended dose is:
One tablet in the morning and one tablet in the evening (12 hours apart). Do not take more than two tablets in one day. You must wait 12 hours between each tablet. Do not take the tablets more often than every 12 hours.
Swallow the tablet whole with water. Do not divide, crush, dissolve, suck, or chew the tablet. This could increase the risk of side effects.
If you take more Fampridine Sun than you should
Contact your doctor immediately if you take too many tablets.
If you go to a doctor, take the Fampridine Sun pack with you.
If you have taken too much, you may notice sweating, small tremors, dizziness, confusion, memory loss (amnesia), and seizures. You may also notice other effects not mentioned here.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service (telephone 91 562 04 20), indicating the medicine and the amount taken.
If you forget to take Fampridine Sun
If you forget to take a tablet, do not take a double dose to make up for the missed doses.
There must always be 12 hours between each tablet.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
More serious side effects
If you have a seizure, stop taking Fampridine Sun and tell your doctor immediately.
If you experience one or more of the following allergic symptoms (hypersensitivity): swelling of the face, mouth, lips, throat, or tongue, redness or itching of the skin, chest tightness, and breathing problems, stop taking Fampridine Sun and go to the doctor immediately.
Other side effects
The following side effects are listed by frequency:
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website (http://www.aemps.gob.es). By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Aluminium/aluminium blister: This medicine does not require any special storage conditions.
PVC/PVDC/Aluminium blister: Store the tablets in the original packaging to protect them from light and moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Fampridine Sun contains
Core of the tablets: hypromellose, povidone, microcrystalline cellulose (E460), magnesium stearate
Coating of the tablets: hypromellose, talc (E553b), ethyl cellulose (E462), triacetin (E1518), titanium dioxide (E171)
Printing ink: shellac (E904), iron oxide black (E172), propylene glycol (E1520), ammonium hydroxide (E527)
Appearance and packaging
Fampridine Sun is a film-coated tablet, 7.65 ± 0.20 mm in diameter, round, biconvex, with beveled edges, and white to off-white in color, with one face smooth and the other face engraved with 429 in black ink.
Fampridine Sun is available in aluminium/aluminium blister packs and PVC/PVDC/aluminium blister packs.
.
Blister packs
Fampridine Sun is available in blister packs of 14 tablets each. Each pack contains 28 tablets (2 blisters), 56 tablets (4 blisters), or 196 tablets (14 blisters).
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132 JH Hoofddorp
Netherlands
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132 JH Hoofddorp
Netherlands
Or
Terapia S.A.
124 Fabricii Street
400632, Cluj-Napoca
Cluj County
Romania
For further information about this medicine, contact the local representative of the marketing authorisation holder
Sun Pharma Laboratorios, S.L.
Rambla de Catalunya 53-55
08007 – Barcelona
Spain
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
France Fampridine SUN
Germany Fampridin BASICS
Netherlands Fampridine SUN
Spain Fampridina SUN 10 mg prolonged-release tablets EFG
United Kingdom (Northern Ireland) Fampridine SUN
Date of last revision of this leaflet: January 2024.
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)